Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Treatment of Obstructive Sleep Apnea With Dronabinol
NCT06477952Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in obstructive sleep apnea (OSA), sponsored by VA Office of Research & Development. Started Aug 2025; status: recruiting.
02
Drugs
dronabinol
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06477952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06477952.